Background: A barrier to eradicating HIV infection is targeting and eliminating latently infected memory CD4+ T cells, which are the main reservoir of latent virus. Our goal is to determine if T cell specific transcription factors restrict HIV transcription in specific T cell subsets to establish and maintain HIV latency. The transcription factor B Lymphocyte-Induced Maturation Protein 1 (Blimp-1) is expressed in B and T cells and upregulated in patients chronically infected with HIV. Blimp-1 inhibits IL-2 transcription and the IL-2 promoter and the HIV long terminal repeat (LTR) share common cis-elements. We hypothesize that Blimp-1 binds to the HIV LTR, inhibits HIV transcription and contributes to HIV latency. Methodology: We used T cell lines and primary human CD4+ T cells to study the role of Blimp-1 in HIV transcription. HIV replication was monitored using luciferase reporters, RT-PCR, and HIV p24 ELISA assays. Binding of Blimp-1 to the HIV LTR was determined using chromatin immunoprecipitation assay. Blimp-1 expression was diminished using shRNA. The levels of Blimp-1 in different T cell subsets were measured using flow cytometry and immunoblots. Results: We show that Blimp-1 is expressed in primary peripheral blood CD4+ T cells and is further induced by T cell activation. However, infection of CD4+ T cells with HIV inhibits the induction of Blimp-1. Importantly, Blimp-1 is differentially expressed in T cell populations and in particular is highly expressed in memory CD4+ T cells which do not support robust HIV replication. Ectopic expression of Blimp-1 in CD4+ T cells represses HIV transcription, whereas decreasing Blimp-1 in memory CD4+ populations activates HIV transcription. Blimp-1 binds downstream of the HIV 5’-LTR in resting primary CD4+ T cells and represses Tat-dependent HIV transcription. Upon T cell activation with anti-CD3 and anti-CD28 antibodies Blimp-1 is released from the HIV LTR and this correlates with significant increase in HIV transcription. Conclusions: We propose a model in which Blimp-1 acts as an HIV restriction factor in memory CD4+ T cells through binding downstream of the HIV LTR and remodeling chromatin. Intrinsic inhibitors of HIV transcription, such as Blimp-1, may provide novel therapeutic targets for purging latent virus from specific cells.